Does neuromuscular electrical stimulation of the proximal leg muscles improve leg muscle endurance, exercise endurance and activity levels in people with lung cancer?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86814835

Enrollment

Registered

2006-09-29

Start date

2005-11-02

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Lung Cancer Lung

Interventions

A pilot study. Block randomisation to one of two groups. Group 1: 4 weeks with NMES device Group 2:- 4 weeks without device followed by 4 weeks with device

Eligibility

Inclusion criteria

Inclusion criteria: 16 people with non-small cell cancer and an East Oncology Group (EOG) performance status of 0 to 1 and who have lost less than 10% of their normal body weight.

Exclusion criteria

Exclusion criteria: 1. Pain or pathology limiting walking ability for the shuttle walking tests or limiting leg exercise on the cybex machine 2. History of ischaemic heart disease 3. Radiotherapy or chemotherapy in the previous 4 weeks as this may increase fatigue 4. Presence of a pacemaker - because the NMES device delivers a small electrical current, it is possible that this will interfere with the functioning of the pacemaker

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026